Strober, B., Gottlieb, A., Tha?i, D., Puig, L., Colombo, M. J., Kundu, S., Kisa, R., & Banerjee, S. (2020). An Oral, Selective Tyrosine Kinase 2 Inhibitor, BMS-986165, Reduced Absolute Psoriasis Area and Severity Index in a Phase 2 Trial in Psoriasis. SKIN The Journal of Cutaneous Medicine, 4(5), s27. https://doi.org/10.25251/skin.4.supp.27